CDK versus GSK-3 inhibition: a purple haze no longer?

Abstract

The ubiquitous ATP binding site offers a global target for protein kinase inhibitors. The corollary is that molecular selectivity with such agents may be difficult to achieve and ascertain. A relevant example is discussed in terms of design and biomedical rationale. 

Topics

Cite this paper

@article{Fischer2003CDKVG, title={CDK versus GSK-3 inhibition: a purple haze no longer?}, author={Peter M. Fischer}, journal={Chemistry & biology}, year={2003}, volume={10 12}, pages={1144-6} }